Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis

doi:10.3748/wjg.v19.i39.6665

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 39

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6416)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

531

HTML

3708

Figures (1-2)

201

Tables (1-2)

133

Sum=4573

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

910

Download

933

Sum=1843

Oct 21, 2013 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Oct 21, 2013; 19(39): 6665-6678
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6665

Table 2 Sensitivity analysis

Index	Total HBV DNA undetectability
Index	RR	P value
Removing the inferior quality trials[13,15,17]	1.26 (1.15, 1.39)	< 0.0001
Using random-effect model	1.24 (1.16, 1.33)	< 0.00001
Using fixed-effect model	1.29 (1.22, 1.37)	< 0.00001

HBV: Hepatitis B virus.

Citation: Ye XG, Su QM. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis. World J Gastroenterol 2013; 19(39): 6665-6678
URL: https://www.wjgnet.com/1007-9327/full/v19/i39/6665.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i39.6665